License Agreements - Additional Information (Details) - USD ($) $ in Thousands	1 Months Ended				12 Months Ended
	Jun. 30, 2024	May 31, 2024	Apr. 30, 2024	Mar. 31, 2024	Dec. 31, 2024
License Agreements [Line Items]
Revenue					$ 167,500
Trace License Agreement
License Agreements [Line Items]
Upfront Payment Received			$ 15,000
Revenue					15,000
Trace License Agreement \| Development And Regulatory Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of clinical and regulatory milestones				$ 80,000
Trace License Agreement \| Sales Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of sales milestones				250,000
Shionogi License Agreement
License Agreements [Line Items]
Upfront Payment Received		$ 150,000
Revenue					150,000
Shionogi License Agreement \| Development And Regulatory Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of clinical and regulatory milestones				275,000
Shionogi License Agreement \| Sales Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of sales milestones				$ 330,000
Neurocrine License Agreement
License Agreements [Line Items]
Upfront Payment Received	$ 2,500
Revenue					$ 2,500
Neurocrine License Agreement \| Development And Regulatory Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of clinical and regulatory milestones		24,800
Neurocrine License Agreement \| Sales Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of sales milestones		$ 175,000